
|Videos|April 27, 2022
Aurion BioTech presents cell therapy findings with published clinical data
Author(s)Kassi Filkins
Greg Kunst, president and CEO of Aurion BioTech, shares a company update on endothelial cell therapy trials, clinical plans and upcoming data.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
ARPA-H funds tear-duct biosensor system for dry eye, systemic disease
2
Memento Medicines launches with $93 million Series A to advance Tie2-activating bispecific for retinal disease
3
DSLT for glaucoma and ocular hypertension: Real-world outcomes in 218 eyes
4
First patient dosed in phase 3 pivotal cohort of LIGHTHOUSE trial evaluating ATSN-201 for X-linked retinoschisis
5


























